Literature DB >> 6090752

Hyperplastic and neoplastic changes in the mammary glands of feral mice free of endogenous mouse mammary tumor virus provirus.

L J Faulkin, D J Mitchell, L J Young, D W Morris, R W Malone, R D Cardiff, M B Gardner.   

Abstract

Laboratory colonies of feral mice (Mus musculus domesticus) have been established with specific mouse mammary tumor virus (MuMTV) genotype, including colonies lacking any proviral DNA (ev-) or carrying only a single copy of MuMTV DNA (ev+). No evidence of a decline in reproductive capacity has been observed in the first 8 generations. Both the ev- and ev+ mice showed normal mammary gland development and the development of hyperplastic lesions in the older females. The mice were very resistant to spontaneous or chemically induced mammary tumors. However, the occurrence of 1 mammary tumor in an ev- mouse indicates that mammary neoplasias can occur in the absence of MuMTV DNA. The few tumors that do occur in the ev- mice provide a unique opportunity to study the neoplastic process in the absence of proviral DNA.

Entities:  

Mesh:

Year:  1984        PMID: 6090752

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  4 in total

Review 1.  The comparative pathology of human and mouse mammary glands.

Authors:  R D Cardiff; S R Wellings
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-01       Impact factor: 2.673

2.  Transfer, by selective breeding, of the pathogenic Mtv-2 endogenous provirus from the GR strain to a wild mouse line free of endogenous and exogenous mouse mammary tumor virus.

Authors:  D W Morris; L J Young; M B Gardner; R D Cardiff
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

Review 3.  Genetic control of retroviral disease in aging wild mice.

Authors:  M B Gardner
Journal:  Genetica       Date:  1993       Impact factor: 1.082

Review 4.  Mus tales: a hands-on view.

Authors:  Lawrence J T Young
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-07-25       Impact factor: 2.673

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.